New 3D bioprinting process involving the University of Huddersfield could save t...
In a world of continuously warmer temperatures, a growing consensus demands that...
“[…] we demonstrated the new acylfulvene compound LP-284 has anti-tumor activity...
As adoption of Continuous Glucose Monitoring (CGM) continues to increase, there ...
NEW ORLEANS, La. – Ochsner Health has named Jim Molloy as the organization’s nex...
Niigata, Japan – The gold standard test for predicting the onset of diabetic kid...
Niigata, Japan – The Department of Neurology at Niigata University has developed...
Uproleselan sodium is under clinical development by GlycoMimetics and currently ...
RT-002 is under clinical development by Revance Therapeutics and currently in Ph...
Pimitespib is under clinical development by Otsuka Pharmaceutical and currently ...
NuGel is under clinical development by Shaperon and currently in Phase I for Sep...
TAS-117 is under clinical development by Taiho Pharmaceutical and currently in P...
VEDVDox is under clinical development by ImmunityBio and currently in Phase I fo...
CIGB-128 is under clinical development by Center for Genetic Engineering and Bio...
Influenza vaccine 2 is under clinical development by Shanghai Institute of Biolo...
PB-357 is under clinical development by Puma Biotechnology and currently in Phas...
